Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	798,527	667,298	285,738	293,298	312,699	493,057
Market Cap Growth	139.39%	133.53%	-2.58%	-6.20%	-36.58%	48.78%
Enterprise Value	891,621	782,098	384,979	380,259	385,923	578,014
Last Close Price	61000.00	51700.00	23000.00	25700.00	27400.00	43250.00
PE Ratio	33.44	26.73	-	-	146.58	-
Forward PE	-	30.73	30.73	30.73	30.73	30.73
PS Ratio	3.82	3.19	1.77	2.35	1.94	2.98
PB Ratio	1.37	1.14	1.91	2.13	1.86	4.96
P/TBV Ratio	1.37	1.15	1.92	2.13	1.88	5.03
P/OCF Ratio	78.22	65.36	-	-	-	-
PEG Ratio	-	94.42	94.42	94.42	94.42	94.42
EV/Sales Ratio	4.27	3.74	2.38	3.05	2.39	3.49
EV/EBITDA Ratio	32.62	28.61	-	-	31.87	37.17
EV/EBIT Ratio	50.74	44.51	-	-	146.09	136.03
Debt / Equity Ratio	0.18	0.18	0.85	0.78	0.44	0.69
Debt / EBITDA Ratio	3.79	3.79	-	-	6.10	4.43
Net Debt / Equity Ratio	0.16	0.16	0.76	0.73	0.40	0.41
Net Debt / EBITDA Ratio	3.41	3.41	-8.64	-6.57	5.58	2.64
Net Debt / FCF Ratio	-3.32	-3.32	-5.12	-2.86	-2.49	-1.99
Asset Turnover	0.31	0.31	0.44	0.40	0.59	0.69
Inventory Turnover	2.98	2.98	2.53	1.65	2.18	2.89
Quick Ratio	0.28	0.28	0.24	0.26	0.33	0.51
Current Ratio	0.64	0.64	0.50	0.82	1.01	1.03
Return on Equity (ROE)	6.81%	6.81%	-64.87%	-22.00%	3.01%	-1.75%
Return on Assets (ROA)	1.65%	1.65%	-3.79%	-4.83%	0.60%	1.10%
Return on Invested Capital (ROIC)	2.99%	3.62%	-8.81%	-10.18%	1.37%	3.26%
Return on Capital Employed (ROCE)	2.40%	2.40%	-10.40%	-13.30%	1.30%	3.10%
Earnings Yield	3.13%	3.74%	-32.58%	-10.48%	0.68%	-0.28%
FCF Yield	-3.51%	-4.20%	-7.80%	-11.94%	-8.69%	-4.18%
Buyback Yield / Dilution	-14.58%	-14.58%	-4.65%	9.69%	-10.85%	-
Total Shareholder Return	-14.58%	-14.58%	-4.65%	9.69%	-10.85%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.